Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on May 2015 |
| Author/s |
author: Chan Yoon Cheah Loretta J Nastoupil Nathan H Fowler Sattva S Neelapu Yasuhiro Oki Sheryl G Forbes |
| Publication date | May 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |